LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

Search

Day One Biopharmaceuticals Inc

Closed

SectorHealthcare

6.43 -4.74

Overview

Share price change

24h

Current

Min

6.35

Max

6.53

Key metrics

By Trading Economics

Income

-103M

-66M

Sales

-65M

29M

EPS

-0.63

Profit margin

-224.986

Employees

181

EBITDA

-94M

-65M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+368.99% upside

Dividends

By Dow Jones

Next Earnings

29 Jul 2025

Market Stats

By TradingEconomics

Market Cap

-425M

804M

Previous open

11.17

Previous close

6.43

News Sentiment

By Acuity

50%

50%

170 / 382 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Day One Biopharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

11 May 2025, 23:48 UTC

Earnings
Acquisitions, Mergers, Takeovers

Dyno Nobel Returns to 1st Half Profit; Strikes Fertilizers Deals -- Update

11 May 2025, 23:46 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-China Trade Talks -- Market Talk

11 May 2025, 23:45 UTC

Market Talk

Oil Rises Amid Improved Market Mood -- Market Talk

11 May 2025, 23:38 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Aristocrat Has Significant Firepower for M&A -- Market Talk

11 May 2025, 23:36 UTC

Market Talk

Global Markets Uncertain About US-China Trade News -- Market Talk

11 May 2025, 23:35 UTC

Market Talk

Gold Falls, Dragged by Weakening Safe-Haven Demand, Possible Profit-Taking -- Market Talk

11 May 2025, 23:33 UTC

Earnings
Acquisitions, Mergers, Takeovers

Dyno Nobel Returns to 1H Profit; Strikes Fertilizers Deals -- Update

11 May 2025, 23:32 UTC

Top News

Proposal Cutting Medicaid Aims for GOP Middle Ground -- WSJ

11 May 2025, 22:44 UTC

Market Talk

Centaurus Metals's Jaguar Project Faces Funding Hurdles -- Market Talk

11 May 2025, 22:33 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Domain Takeover Could Create Near-Term Overhang on REA Stock -- Market Talk

11 May 2025, 20:19 UTC

Top News

Bessent Says U.S.-China Trade Talks Were 'Productive,' Without Offering Specifics -- WSJ

11 May 2025, 16:00 UTC

Top News

Trump's Budget Hawk Takes Over the DOGE Agenda. First Up: the Military -- WSJ

11 May 2025, 11:00 UTC

Top News

This Obscure New York Court Is Set to Decide Fate of Trump's Tariffs -- WSJ

11 May 2025, 08:00 UTC

Top News

China's Property Market Is a Tale of Big Cities. Everywhere Else Is Struggling. -- Barrons.com

11 May 2025, 01:00 UTC

Top News

The Spring Home Sales Season Is Shaping Up to Be a Dud -- WSJ

11 May 2025, 01:00 UTC

Top News

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia on Cease-Fire -- WSJ

10 May 2025, 21:54 UTC

Top News

GOP Tax Bill Seeks to Put Cash in Taxpayers' Pockets in Early 2026 -- Update

10 May 2025, 17:12 UTC

Top News

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia to Cease Fire -- WSJ

10 May 2025, 15:41 UTC

Top News

Fed Officials Signal Pause on Adjusting Interest Rates as Trade Risks Mount -- Barrons.com

10 May 2025, 12:00 UTC

Top News

Why a Sorority Is Taking on Trump's Budget Cuts -- WSJ

10 May 2025, 09:30 UTC

Top News

The Giants of Silicon Valley Are Having a Midlife Crisis Over AI -- WSJ

10 May 2025, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

10 May 2025, 03:52 UTC

Top News

China Struggles With Persistent Disinflationary Pressures as Tariffs Bite -- WSJ

9 May 2025, 23:51 UTC

Acquisitions, Mergers, Takeovers

Oil at $50? The High Cost of Cheap Crude. -- Barrons.com

9 May 2025, 22:06 UTC

Market Talk

Arm Holdings Remains a Strong Growth Story -- Market Talk

9 May 2025, 21:37 UTC

Top News

U.S. Sets August Deadline for Debt Ceiling -- WSJ

9 May 2025, 21:10 UTC

Top News

The Score: Disney, Berkshire Hathaway, Ford and More Stocks That Defined the Week -- WSJ

9 May 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

9 May 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

9 May 2025, 20:42 UTC

Top News

Stocks Get a Break From Trade Chaos -- WSJ

Peer Comparison

Price change

Day One Biopharmaceuticals Inc Forecast

Price Target

By TipRanks

368.99% upside

12 Months Forecast

Average 30.25 USD  368.99%

High 40 USD

Low 20 USD

Based on 9 Wall Street analysts offering 12 month price targets forDay One Biopharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

8

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

6.26 / 7.47Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

170 / 382 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.